EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0

Autor: David J. Brooks, Ronald Boellaard, Adriaan A. Lammertsma, Giuseppe Esposito, Peter Herscovitch, Michele Wanner, Phillip H. Kuo, John Dickson, Ian Law, Jacob Dubroff, George Zubal, Elsmarieke van de Giessen, Ozgul Ekmekcioglu, Valentina Garibotto, Sabina Pappatà, N.I. Bohnen, Andrea Varrone, David B. Douglas, Iván Peñuelas, Alexander Drzezga, John Seibyl, Koen Van Laere, Franck Semah, Jacques Darcourt, Silvia Morbelli, Javier Arbizu, Livia Tossici-Bolt, Henryk Barthel
Přispěvatelé: Radiology and Nuclear Medicine, Radiology and nuclear medicine, Amsterdam Neuroscience - Brain Imaging, Amsterdam Movement Sciences, AMS - Tissue Function & Regeneration
Jazyk: angličtina
Rok vydání: 2020
Předmět:
medicine.medical_specialty
I-123-IOFLUPANE SPECT IMAGES
HEALTHY CONTROLS
Guidelines
Single-photon emission computed tomography
ddc:616.0757
Parkinsonian syndromes
POSITRON-EMISSION-TOMOGRAPHY
I-123-FP-CIT SPECT
Brain
DAT
DOPA
Parkinson
PET
SPECT
Parkinsonian Disorders
Spect imaging
medicine
Humans
Radiology
Nuclear Medicine and imaging
Medical physics
Fluorodopa
ddc:610
Radionuclide Imaging
Dopamine transporter
Tomography
Emission-Computed
Single-Photon
biology
medicine.diagnostic_test
business.industry
Dopaminergic
General Medicine
Guideline
PROGRESSIVE SUPRANUCLEAR PALSY
diagnostic imaging [Parkinsonian Disorders]
LEWY BODIES
POINT-SPREAD FUNCTION
Molecular Imaging
biology.protein
TRANSPORTER AVAILABILITY
WHOLE-BODY BIODISTRIBUTION
Molecular imaging
DIFFERENTIAL-DIAGNOSIS
Nuclear Medicine
business
Zdroj: European journal of nuclear medicine and molecular imaging 47(8), 1885-1912 (2020). doi:10.1007/s00259-020-04817-8
Morbelli, S, Esposito, G, Arbizu, J, Barthel, H, Boellaard, R, Bohnen, N I, Brooks, D J, Darcourt, J, Dickson, J C, Douglas, D, Drzezga, A, Dubroff, J, Ekmekcioglu, O, Garibotto, V, Herscovitch, P, Kuo, P, Lammertsma, A, Pappata, S, Peñuelas, I, Seibyl, J, Semah, F, Tossici-Bolt, L, Van de Giessen, E, Van Laere, K, Varrone, A, Wanner, M, Zubal, G & Law, I 2020, ' EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0 ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 47, no. 8, pp. 1885-1912 . https://doi.org/10.1007/s00259-020-04817-8
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, No 8 (2020) pp. 1885-1912
Morbelli, S, Esposito, G, Arbizu, J, Barthel, H, Boellaard, R, Bohnen, N, Brooks, D J, Darcourt, J, Dickson, J C, Douglas, D, Drzezga, A, Dubroff, J, Ekmekcioglu, O, Garibotto, V, Herscovitch, P, Kuo, P, Lammertsma, A, Pappata, S, Penuelas, I, Seibyl, J, Semah, F, Tossici-Bolt, L, Van de Giessen, E, Van Laere, K, Varrone, A, Wanner, M, Zubal, G & Law, I 2020, ' EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0 ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 47, no. 8, pp. 1885-1912 . https://doi.org/10.1007/s00259-020-04817-8
European journal of nuclear medicine and molecular imaging, 47(8), 1885-1912. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 47(8), 1885-1912. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging
ISSN: 1619-7070
DOI: 10.1007/s00259-020-04817-8
Popis: Purpose This joint practice guideline or procedure standard was developed collaboratively by the European Association of Nuclear Medicine (EANM) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI). The goal of this guideline is to assist nuclear medicine practitioners in recommending, performing, interpreting, and reporting the results of dopaminergic imaging in parkinsonian syndromes. Methods Currently nuclear medicine investigations can assess both presynaptic and postsynaptic function of dopaminergic synapses. To date both EANM and SNMMI have published procedural guidelines for dopamine transporter imaging with single photon emission computed tomography (SPECT) (in 2009 and 2011, respectively). An EANM guideline for D2 SPECT imaging is also available (2009). Since the publication of these previous guidelines, new lines of evidence have been made available on semiquantification, harmonization, comparison with normal datasets, and longitudinal analyses of dopamine transporter imaging with SPECT. Similarly, details on acquisition protocols and simplified quantification methods are now available for dopamine transporter imaging with PET, including recently developed fluorinated tracers. Finally, [18F]fluorodopa PET is now used in some centers for the differential diagnosis of parkinsonism, although procedural guidelines aiming to define standard procedures for [18F]fluorodopa imaging in this setting are still lacking. Conclusion All these emerging issues are addressed in the present procedural guidelines for dopaminergic imaging in parkinsonian syndromes.
Databáze: OpenAIRE
Externí odkaz: